← Back to Search

Diagnostic Test

Known ICA Fibromuscular Dysplasia for Carotid Artery Stenosis

N/A
Waitlist Available
Led By Imad Bagh, MD
Research Sponsored by The Cleveland Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Summary

The purpose of this study is to determine the accuracy of a new non-invasive device, the Carotid Stenotic Scan (CSS), to check for stenosis of the internal carotid artery (ICA) as compared to a carotid ultrasound study.

Eligible Conditions
  • Carotid Artery Stenosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Comparison of CSS readings to conventional carotid artery duplex ultrasound
Secondary outcome measures
Reproducibility of the CSS measurement

Trial Design

3Treatment groups
Experimental Treatment
Group I: Unknown/Normal/Mild DiseaseExperimental Treatment1 Intervention
No prior carotid duplex study or known normal or mild disease in the ICAs (PSV \<= 125 cm/sec)
Group II: Known moderate or severe ICA Stenosis (PSV>125 cm/sec)Experimental Treatment1 Intervention
Group III: Known ICA Fibromuscular DysplasiaExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor
1,045 Previous Clinical Trials
1,370,624 Total Patients Enrolled
CVR Global, Inc.Industry Sponsor
1 Previous Clinical Trials
414 Total Patients Enrolled
Imad Bagh, MDPrincipal InvestigatorThe Cleveland Clinic
~7 spots leftby Sep 2025